Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS

Neurology

Volumn 59, Issue 4, 2002, Pages 555-559

  Villar, Luisa María ^a   Masjuan, J ^a   Gonzalez Porque P ^a   Plaza, J ^a   Sadaba M C ^a   Roldan E ^a   Bootello, A ^a   Alvarez Cermeno J C ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; IMMUNOGLOBULIN M; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CORRELATION ANALYSIS; DISABILITY; DISEASE COURSE; DRUG SYNTHESIS; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; MULTIPLE SCLEROSIS; POLYCLONAL ACTIVATION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RELAPSE; SCORING SYSTEM;

EID: 0037183478     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.4.555     Document Type: Article

References (25)

1. The application of multi-factorial cluster analysis in the staging of plaques in early multiple sclerosis
2. Identification of autoantibodies associated with myelin damage in multiple sclerosis
3. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
4. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
5. Immunopathology of secondary-progressive multiple sclerosis
6. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis
7. CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high-dose intravenous methylprednisolone
8. Intrathecal IgM synthesis in neurological diseases. Relationship with disability in MS
9. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
10. Isoelectric focusing of cerebrospinal fluid immunoglobulin G: An annotated update
11. Description of a sensitive and reproducible method for the detection of oligoclonal IgM bands
12. Intrathecal synthesis of IgM and IgA in neurological diseases: Comparison of two formulae with isoelectric focusing
13. Intrathecal immunoglobulin M synthesis in multiple sclerosis
14. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis, I: Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
15. Intramuscular interferon beta-la for disease progression in relapsing multiple sclerosis: The Multiple Sclerosis Collaborative Research Group (MSCRG)
16. Randomised double blind, placebo controlled study of interferon beta-la in relapsing-remitting multiple sclerosis
17. Optic neuritis: Prognosis for multiple sclerosis from MRI, CSF, and HLA findings
18. Isolated demyelinating syndromes: Comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis
19. The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis
20. 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis
21. High prevalence of anti-α-crystallin antibodies in multiple sclerosis: Correlation with severity and activity of disease
22. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis
23. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine
24. Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
25. Multiple sclerosis is associated with enhanced B cell response to the ganglioside GDla